Navigation Links
Study finds patient navigation increases colorectal cancer screening in ethnically diverse patients
Date:5/23/2011

(Boston) Researchers from Boston University School of Medicine, Cambridge Health Alliance and Harvard Medical School have found targeting patient navigation to black and non-English speaking patients may be one approach to reducing disparities in colorectal cancer (CRC) screenings. These findings appear in the May 23 issue of the Archives of Internal Medicine.

Colorectal cancer is the second leading cause of cancer death in the U.S. and is preventable through screening. Nevertheless, about 40 percent of eligible adults in the U.S. and more foreign born U.S. residents are overdue for CRC screening. Patients at greatest risk of not being screened include minorities, patients with Medicaid or no health insurance, those who are foreign-born and patients of low socioeconomic status.

Patient navigators are non-clinical staff members who guide patients through the health care system so that they receive appropriate services. The navigators perform a wide range of advocacy and coordination activities, such as assisting patients in obtaining health insurance or transportation to appointments.

The researchers identified 465 primary care patients from four community health centers and two public hospital-based clinics who were not up-to-date with CRC screening and spoke English, Haitian Creole, Portuguese or Spanish. They randomly allocated patients to receive a patient navigation-based intervention or usual care. Intervention patients received an introductory letter from their primary care provider with educational material followed by telephone calls from a language-concordant navigator. The navigators offered patients the option of being screened by fecal occult blood testing or colonoscopy. The primary outcome was completion of any CRC screening within 12 months. Secondary outcomes included the proportions of patients screened by colonoscopy and who had adenomas or cancer detected.

Over a 12 month period, the researchers found that intervention patients were more likely to undergo CRC screening than control patients (33.6 percent vs. 20.0 percent), to be screened by colonoscopy (26.4 percent vs. 13.0 percent) and to have adenomas detected (8.1 percent vs. 3.9 percent).

"Patient navigation increased CRC screening rates substantially among ethnically and linguistically diverse patients served by urban community health centers and public hospital-based clinics," said lead author Karen Lasser, MD, MPH, an associate professor of medicine and public health at BUSM and Boston University School of Public Health and a primary care physician at Boston Medical Center.

Focusing patient navigation on populations of black and non-English speaking patients may be a particularly effective approach to reducing CRC screening disparities for these patients. Future research should assess how health systems can sustain this benefit when patient navigation is implemented as a routine component of primary care.


'/>"/>

Contact: Jenny Eriksen Leary
jenny.eriksen@bmc.org
617-638-6841
Boston University Medical Center
Source:Eurekalert

Related medicine news :

1. Study links acetaminophen to lower prostate cancer risk
2. Some Dentists Reluctant to Treat Kids on Medicaid: Study
3. Younger Docs More Likely to Prescribe Drugs for Heart Disease: Study
4. Common test could help predict early death in diabetes, study shows
5. Study identifies novel role for a protein that could lead to new treatments for rheumatoid arthritis
6. EMPHASIS HF: Study shows epleronone to reduce atrial fibrillation
7. Robotic Surgery Oversold on Hospital Websites, Study Contends
8. Driving Skills Do Ebb With Age: Study
9. Study Sees Link Between Psoriasis, Obesity in Kids
10. Study Suggests Supplement May Protect Against Preeclampsia
11. Enlarged prostate: Study demonstrates immediate and long-term benefits of laser treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2017)... ... May 26, 2017 , ... Leading CEOs from biotech, ... 30th and 31st at The Four Seasons Hotel Boston. , The Boston ... sciences, offering exclusive access to key decision makers who influence deal making and ...
(Date:5/26/2017)... ... May 26, 2017 , ... Somnoware, a leading ... sleep monitor with its Somnoware Sleep Device Interface (SDI). Somnoware SDI is a ... operations. With this platform, initializing devices and importing studies are just one-click operations. ...
(Date:5/26/2017)... ... May 26, 2017 , ... via seating ... mesh back 24/7 task chair specifically designed for clinical areas. Genie Copper Mesh ... to partner with Cupron® to provide customers with a game changing chair that ...
(Date:5/26/2017)... Abilene, Texas (PRWEB) , ... May 26, 2017 , ... ... released a new publication this week that is focusing on the Peace Agreements being ... begun his Middle East sprint in a race to try to speed up peace ...
(Date:5/26/2017)... ... ... Dr. Alex Rabinovich, a highly-skilled oral surgeon specializing in wisdom teeth extraction ... options. If a Bay Area patient has to search for a second opinion before ... in-network provider for a second opinion can ensure a patient receives the full benefits ...
Breaking Medicine News(10 mins):
(Date:5/18/2017)... -- Bayer announced today that the latest research from across ... 53 rd Annual Meeting of the American Society ... Chicago . The ... and thyroid cancers, as well as lymphomas, and includes ... of copanlisib in patients with relapsed or refractory follicular ...
(Date:5/10/2017)... -- Hologic, Inc. (Nasdaq: HOLX ) announced ... quarter ended April 1, 2017 .   GAAP diluted ... to the prior year period as the sale of ... while non-GAAP diluted EPS of $0.50 increased 6.4%.  Revenue ... currency terms.  Excluding the effects of blood screening and ...
(Date:5/9/2017)... Zimmer Biomet Holdings, Inc. (NYSE and SIX: ... it has earned a spot on Forbes, ... was ranked among 500 U.S. employers as well as ... and Services. The annual Forbes ... survey of over 30,000 employees across 25 industries. The ...
Breaking Medicine Technology: